# A New Hope for the Treatment of Atrial Fibrillation: Application of Pulsed-Field Ablation Technology

## TL;DR

This paper reviews pulsed-field ablation (PFA) as a promising new treatment for atrial fibrillation, offering higher safety and effectiveness compared to existing methods.

## Contribution

The paper provides a comprehensive review of PFA technology's development and experimental outcomes for treating atrial fibrillation.

## Key findings

- PFA can achieve pulmonary vein isolation without damaging nearby structures like the phrenic nerve and esophagus.
- Animal studies show PFA has higher safety and shorter procedure times compared to traditional ablation techniques.
- PFA is being explored through simulation, animal, and clinical studies to improve atrial fibrillation treatment.

## Abstract

In recent years, the prevalence of and mortality associated with cardiovascular diseases have been rising in most countries and regions. AF is the most common arrhythmic condition, and there are several treatment options for AF. Pulmonary vein isolation is an effective treatment for AF and is the cornerstone of current ablation techniques, which have one major limitation: even when diagnosed and treated at a facility that specializes in ablation, patients have a greater chance of recurrence. Therefore, there is a need to develop better ablation techniques for the treatment of AF. This article first compares the current cryoablation (CBA) and radiofrequency ablation (RFA) techniques for the treatment of AF and discusses the utility and advantages of the development of pulsed-field ablation (PFA) technology. The current research on PFA is summarized from three perspectives, namely, simulation experiments, animal experiments, and clinical studies. The results of different stages of experiments are summarized, especially during animal studies, where pulmonary vein isolation was carried out effectively without causing injury to the phrenic nerve, esophagus, and pulmonary veins, with higher safety and shorter incision times. This paper focuses on a review of various a priori and clinical studies of this new technique for the treatment of AF.